SCHEMBL24073682

SCHEMBL24073682

CNC(=O)Nc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ RECQL P46063 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ STAT3 P40763 3/20 0.40
▸ RAB9A P51151 6/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ PKM P14618 2/20 0.39
▸ MAPT P10636 3/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ MLNR O43193 1/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ ADRB2 P07550 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134415 0.89 RAB9A (0.44) ALDH1A1SMN1; SMN2KDM4ESTAT3RAB9A
SCHEMBL24072387 0.88 KDM4E (0.44) ALDH1A1SMN1; SMN2KDM4ESTAT3RAB9A
SCHEMBL24073667 0.87 CCNE1 (0.44) ALDH1A1KDM4ESTAT3RAB9ANPC1
SCHEMBL24072396 0.86 STAT3 (0.44) ALDH1A1SMN1; SMN2STAT3RAB9ANPC1
SCHEMBL24073675 0.86 KDM4E (0.43) ALDH1A1SMN1; SMN2KDM4ESTAT3RAB9A
SCHEMBL27134412 0.84 CCNE1 (0.44) ALDH1A1SMN1; SMN2KDM4ESTAT3RAB9A
SCHEMBL24073673 0.84 KDM4E (0.58) ALDH1A1KDM4ERAB9ANPC1MEN1
SCHEMBL24072390 0.83 JAK2 (0.47) ALDH1A1SMN1; SMN2KDM4ESTAT3RAB9A
SCHEMBL27134416 0.82 TSHR (0.51) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL24072309 0.82 MEN1 (0.49) ALDH1A1KDM4ESTAT3RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885SMN1; SMN2 2621/4885RECQL 384/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885SMN1; SMN2 2621/4885RECQL 384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback